William McIsaac is an Associate at Sagard Holdings and is based in Toronto where he is responsible for intellectual property and structured credit investments in the life sciences sector. Prior to this role, William was an Analyst at DRI Capital where he was responsible for making royalty and structured credit investments in the biopharmaceutical industry. Will transitioned into investments from scientific research after finishing his MBA at Queen’s.